I. Moseley

发表

Detection of multiple sclerosis by magnetic resonance imaging

G. Barker, D. MacManus, P. Tofts, 1994, The Lancet.

Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival

John E. Wright, C. Bunce, I. Cree, 2000, The British journal of ophthalmology.

ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 IN WEST-INDIAN-BORN UK RESIDENTS WITH SPASTIC PARAPARESIS

M. Newton, P. Rudge, A. Dalgleish, 1987, The Lancet.

Clinical features associated with survival of patients with lymphoma of the ocular adnexa

I. Cree, G. Rose, P. Plowman, 2003, Eye.

PATHOGENESIS OF PROGRESSIVE MULTIPLE SCLEROSIS

D. MacManus, A. Kermode, W. Mcdonald, 1989, The Lancet.

CAMPATH-1H in multiple sclerosis

A. Compston, A. Coles, G. Hale, 1996, Multiple sclerosis.

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis

A. Compston, A. Compston, G. Hale, 1994, The Lancet.

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.

E. Cabanis, M. Clanet, V. Dousset, 1997, Journal of neurology, neurosurgery, and psychiatry.

Primary orbital melanoma masquerading as vascular anomalies

I. Cree, G. Rose, J. Hungerford, 2002, Eye.